Xilio Therapeutics, Inc. (XLO) — Analyst estimates
Consensus analyst estimates for Xilio Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 4.90M | -0.92 | 1 |
| 2027 | 2.70M | -0.92 | 1 |
| 2028 | 7.43M | -3.64 | 1 |
| 2029 | 4.15M | -2.9 | 1 |
| 2030 | 2.34M | -2.85 | 1 |
Consensus analyst estimates by fiscal year.